A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings
- PMID: 12818869
- DOI: 10.2214/ajr.181.1.1810253
A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings
Abstract
Objective: The purpose of our study was to evaluate the effectiveness of intraarterial infusion of paclitaxel incorporated into human albumin nanoparticles for use as induction chemotherapy before definitive treatment of advanced squamous cell carcinoma of the tongue.
Subjects and methods: Twenty-three previously untreated patients (age range, 27-75 years) who had carcinoma of the tongue (stage T3-T4, any N) received intraarterial therapy with paclitaxel incorporated into albumin nanoparticles delivered by transfemoral catheterization into the external carotid artery (10 patients), selectively into the lingual artery (12 patients), or into a faciolingual trunk (1 patient). Each patient received two to four infusions, with a 3-week interval between infusions. The dose administered was 230 mg/m(2) in eight patients, 180 mg/m(2) in six patients, and 150 mg/m(2) in nine patients. Sixteen patients underwent surgery. Of these 16 patients, eight subsequently received radiotherapy, and three received a combination of chemotherapy and radiotherapy. Of the remaining seven patients, one received chemotherapy alone, four received radiotherapy alone, one received chemotherapy plus radiotherapy, and one refused any further treatment.
Results: Sixty-seven infusions were performed successfully. Eighteen patients (78%) had a clinical and radiologic objective response (complete, 26%; partial, 52%). Three patients (13%) showed stable disease, and two (9%) showed disease progression. The four patients with complete clinical response who underwent surgery showed microscopic residual carcinoma measuring less than 1 mm in two patients, less than 5 mm in one patient, and less than 1 cm in one patient. The toxicities encountered were hematologic (grade 3) in two patients (8.6%) and neurologic (grade 4) in two patients (reversible paralysis of the facial nerve, 8.6%). Two catheter-related complications occurred: one reversible brachiofacial paralysis and one asymptomatic occlusion of the external carotid artery.
Conclusion: Intraarterial infusion of paclitaxel in albumin nanoparticles proved reproducible and effective and deserves further investigation as induction chemotherapy before definitive treatment of advanced tumors of the tongue, with a view to organ preservation.
Similar articles
-
Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.J Vasc Interv Radiol. 2007 Nov;18(11):1395-403. doi: 10.1016/j.jvir.2007.06.009. J Vasc Interv Radiol. 2007. PMID: 18003990 Clinical Trial.
-
Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.Semin Oncol. 1996 Oct;23(5 Suppl 12):55-8. Semin Oncol. 1996. PMID: 8941411 Clinical Trial.
-
Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.Head Neck. 2007 Apr;29(4):315-24. doi: 10.1002/hed.20522. Head Neck. 2007. PMID: 17252600 Clinical Trial.
-
Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.Semin Oncol. 2000 Feb;27(1 Suppl 1):23-7. Semin Oncol. 2000. PMID: 10697040 Review.
-
Treatment of patients with upper gastrointestinal carcinomas.Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-72-S19-76. Semin Oncol. 1997. PMID: 9427271 Review.
Cited by
-
Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.Int J Nanomedicine. 2014 Aug 8;9:3719-35. doi: 10.2147/IJN.S61670. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25143724 Free PMC article. Review.
-
Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.Eur J Pharm Sci. 2012 Feb 14;45(3):320-9. doi: 10.1016/j.ejps.2011.11.017. Epub 2011 Dec 3. Eur J Pharm Sci. 2012. PMID: 22155544 Free PMC article.
-
Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.Cancers (Basel). 2022 Dec 30;15(1):268. doi: 10.3390/cancers15010268. Cancers (Basel). 2022. PMID: 36612264 Free PMC article. Review.
-
Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids.J Drug Target. 2005 Jan;13(1):73-80. doi: 10.1080/10611860400011935. J Drug Target. 2005. PMID: 15848957 Free PMC article.
-
Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results.Br J Cancer. 2004 Apr 5;90(7):1323-8. doi: 10.1038/sj.bjc.6601674. Br J Cancer. 2004. PMID: 15054449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources